These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 28751674)

  • 21. Functional selective FPR1 signaling in favor of an activation of the neutrophil superoxide generating NOX2 complex.
    Lind S; Dahlgren C; Holmdahl R; Olofsson P; Forsman H
    J Leukoc Biol; 2021 Jun; 109(6):1105-1120. PubMed ID: 33040403
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The peptidomimetic Lau-(Lys-βNSpe)
    Skovbakke SL; Winther M; Gabl M; Holdfeldt A; Linden S; Wang JM; Dahlgren C; Franzyk H; Forsman H
    Biochem Pharmacol; 2016 Nov; 119():56-65. PubMed ID: 27614010
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural changes of the ligand and of the receptor alters the receptor preference for neutrophil activating peptides starting with a formylmethionyl group.
    Forsman H; Winther M; Gabl M; Skovbakke SL; Boulay F; Rabiet MJ; Dahlgren C
    Biochim Biophys Acta; 2015 Jan; 1853(1):192-200. PubMed ID: 25447672
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PKC-delta controls the fMLF-induced overproduction of superoxide by neutrophils.
    Matron C; Chakravarti A; Allaeys I; Poubelle PE
    Free Radic Biol Med; 2010 Jan; 48(2):207-15. PubMed ID: 19854263
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacological profile of a bifunctional ligand of the formyl peptide receptor1 fused to the myc epitope.
    Charest-Morin X; Roy C; Fernandes MJ; Marceau F
    Int Immunopharmacol; 2015 Mar; 25(1):229-34. PubMed ID: 25681283
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Honokiol causes the p21WAF1-mediated G(1)-phase arrest of the cell cycle through inducing p38 mitogen activated protein kinase in vascular smooth muscle cells.
    Lee B; Kim CH; Moon SK
    FEBS Lett; 2006 Oct; 580(22):5177-84. PubMed ID: 16962592
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The hederagenin saponin SMG-1 is a natural FMLP receptor inhibitor that suppresses human neutrophil activation.
    Hwang TL; Wang CC; Kuo YH; Huang HC; Wu YC; Kuo LM; Wu YH
    Biochem Pharmacol; 2010 Oct; 80(8):1190-200. PubMed ID: 20599799
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of formyl peptide receptor 1 (FPR1) in neuroblastoma tumorigenesis.
    Snapkov I; Öqvist CO; Figenschau Y; Kogner P; Johnsen JI; Sveinbjørnsson B
    BMC Cancer; 2016 Jul; 16():490. PubMed ID: 27432059
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gastrin-releasing peptide/neuromedin B receptor antagonists PD176252, PD168368, and related analogs are potent agonists of human formyl-peptide receptors.
    Schepetkin IA; Kirpotina LN; Khlebnikov AI; Jutila MA; Quinn MT
    Mol Pharmacol; 2011 Jan; 79(1):77-90. PubMed ID: 20943772
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A non-peptide receptor inhibitor with selectivity for one of the neutrophil formyl peptide receptors, FPR 1.
    Cevik-Aras H; Kalderén C; Jenmalm Jensen A; Oprea T; Dahlgren C; Forsman H
    Biochem Pharmacol; 2012 Jun; 83(12):1655-62. PubMed ID: 22410002
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting formyl peptide receptor 1 with anteiso-C13-surfactin for neutrophil-dominant acute respiratory distress syndrome.
    Yang SC; Wang YH; Ho CM; Tsai YF; Sung PJ; Lin TE; Hwang TL
    Br J Pharmacol; 2023 Aug; 180(16):2120-2139. PubMed ID: 36929355
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proresolving and tissue-protective actions of annexin A1-based cleavage-resistant peptides are mediated by formyl peptide receptor 2/lipoxin A4 receptor.
    Dalli J; Consalvo AP; Ray V; Di Filippo C; D'Amico M; Mehta N; Perretti M
    J Immunol; 2013 Jun; 190(12):6478-87. PubMed ID: 23686496
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mitocryptide-2: Identification of Its Minimum Structure for Specific Activation of FPR2-Possible Receptor Switching from FPR2 to FPR1 by Its Physiological C-terminal Cleavages.
    Marutani T; Nishino K; Miyaji T; Kamada K; Ohura K; Kiso Y; Mukai H
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33920954
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural Determinants in the
    Viklund M; Fredriksson J; Holdfeldt A; Lind S; Franzyk H; Dahlgren C; Sundqvist M; Forsman H
    J Immunol; 2022 Apr; 208(7):1632-1641. PubMed ID: 35321878
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Formyl peptide derived lipopeptides disclose differences between the receptors in mouse and men and call the pepducin concept in question.
    Winther M; Holdfeldt A; Sundqvist M; Rajabkhani Z; Gabl M; Bylund J; Dahlgren C; Forsman H
    PLoS One; 2017; 12(9):e0185132. PubMed ID: 28934373
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum amyloid A mediates human neutrophil production of reactive oxygen species through a receptor independent of formyl peptide receptor like-1.
    Björkman L; Karlsson J; Karlsson A; Rabiet MJ; Boulay F; Fu H; Bylund J; Dahlgren C
    J Leukoc Biol; 2008 Feb; 83(2):245-53. PubMed ID: 17984291
    [TBL] [Abstract][Full Text] [Related]  

  • 37. V101L of human formyl peptide receptor 1 (FPR1) increases receptor affinity and augments the antagonism mediated by cyclosporins.
    Zhou C; Zhou Y; Wang J; Feng Y; Wang H; Xue J; Chen Y; Ye RD; Wang MW
    Biochem J; 2013 Apr; 451(2):245-55. PubMed ID: 23373827
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Two Formyl Peptide Receptors Differently Regulate GPR84-Mediated Neutrophil NADPH Oxidase Activity.
    Mårtensson J; Sundqvist M; Manandhar A; Ieremias L; Zhang L; Ulven T; Xie X; Björkman L; Forsman H
    J Innate Immun; 2021; 13(4):242-256. PubMed ID: 33789297
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The FPR2-specific ligand MMK-1 activates the neutrophil NADPH-oxidase, but triggers no unique pathway for opening of plasma membrane calcium channels.
    Karlsson J; Stenfeldt AL; Rabiet MJ; Bylund J; Forsman HF; Dahlgren C
    Cell Calcium; 2009 May; 45(5):431-8. PubMed ID: 19282028
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of FAM3D as a new endogenous chemotaxis agonist for the formyl peptide receptors.
    Peng X; Xu E; Liang W; Pei X; Chen D; Zheng D; Zhang Y; Zheng C; Wang P; She S; Zhang Y; Ma J; Mo X; Zhang Y; Ma D; Wang Y
    J Cell Sci; 2016 May; 129(9):1831-42. PubMed ID: 26966188
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.